BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28804838)

  • 1. Platelet Function Tests: Preanalytical Variables, Clinical Utility, Advantages, and Disadvantages.
    Hvas AM; Grove EL
    Methods Mol Biol; 2017; 1646():305-320. PubMed ID: 28804838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet Function Analyzed by Light Transmission Aggregometry.
    Hvas AM; Favaloro EJ
    Methods Mol Biol; 2017; 1646():321-331. PubMed ID: 28804839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function tests: a comparative review.
    Paniccia R; Priora R; Liotta AA; Abbate R
    Vasc Health Risk Manag; 2015; 11():133-48. PubMed ID: 25733843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function testing: methods of assessment and clinical utility.
    Mylotte D; Foley D; Kenny D
    Cardiovasc Hematol Agents Med Chem; 2011 Jan; 9(1):14-24. PubMed ID: 21121898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Function Tests.
    Lordkipanidzé M
    Semin Thromb Hemost; 2016 Apr; 42(3):258-67. PubMed ID: 26926583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.
    Koltai K; Kesmarky G; Feher G; Tibold A; Toth K
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function tests and flow cytometry to monitor antiplatelet therapy.
    Matzdorff A
    Semin Thromb Hemost; 2005; 31(4):393-9. PubMed ID: 16149015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Function Testing: Update and Future Directions.
    Larsen JB; Hvas AM; Hojbjerg JA
    Semin Thromb Hemost; 2023 Sep; 49(6):600-608. PubMed ID: 36384230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
    Enko D; Mangge H; Münch A; Niedrist T; Mahla E; Metzler H; Prüller F
    Biochem Med (Zagreb); 2017 Feb; 27(1):217-224. PubMed ID: 28392742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear-induced platelet aggregation in aspirin-treated patients: initial experience with the novel PlaCor PRT device.
    Würtz M; Hvas AM; Wulff LN; Kristensen SD; Grove EL
    Thromb Res; 2012 Nov; 130(5):753-8. PubMed ID: 22995532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light transmission aggregometry.
    Frontroth JP
    Methods Mol Biol; 2013; 992():227-40. PubMed ID: 23546717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
    Gremmel T; Koppensteiner R; Panzer S
    PLoS One; 2015; 10(6):e0129666. PubMed ID: 26058047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry.
    Favaloro EJ
    Clin Chem Lab Med; 2011 Apr; 49(4):737-9. PubMed ID: 21275810
    [No Abstract]   [Full Text] [Related]  

  • 14. Tests of platelet function.
    Shah U; Ma AD
    Curr Opin Hematol; 2007 Sep; 14(5):432-7. PubMed ID: 17934348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow Cytometry Protocols for Assessment of Platelet Function in Whole Blood.
    Pasalic L; Pennings GJ; Connor D; Campbell H; Kritharides L; Chen VM
    Methods Mol Biol; 2017; 1646():369-389. PubMed ID: 28804842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PlaCor PRT measurement of shear-activated platelet aggregate formation in stable patients treated with single and dual antiplatelet therapy.
    Godino C; Pavon AG; Mangieri A; Viani GM; Galaverna S; Spartera M; Chieffo A; Cappelletti A; Margonato A; Colombo A
    Platelets; 2014; 25(5):337-42. PubMed ID: 23971989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care platelet function testing.
    Harle CC
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):247-51. PubMed ID: 18270186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement.
    Gorog DA; Becker RC
    J Thromb Thrombolysis; 2021 Jan; 51(1):1-11. PubMed ID: 32529549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.